Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 3 Left Ventricular Function According to Early and Late Abciximab
Left ventricular function according to early (blue bars) and late (red bars) abciximab. Ejection fraction (EF) (left) and wall motion score index (WMSI) (right) at baseline and at 1 month after primary angioplasty, and mean gain in EF and WMSI between the 2 time points. In the early abciximab patients, both functional parameters were significantly better compared with late abciximab patients (left: p = 0.014 vs. late group; right: p = 0.014 vs. late group); in the same patients, the mean gain in EF (left: p = 0.023 vs. late group) and in WMSI (right: p = 0.031 vs. late group) was significantly higher. Error bars indicate SDs of the mean.
|
